This peptide, consisting of lysine, proline, and valine, has shown significant promise in modulating the body's inflammatory responses, making it a subject of great interest in medical research
As a Category 2 bulk drug substance, BPC-157 lacks FDA approval, making product purity and dosage uncertain
The World Anti-Doping Agency has banned these compounds, noting they lack approval from any health regulatory authority and are intended only as research tools
It was first identified in human plasma and has since become a major subject of interest in regenerative biology, tissue engineering, and extracellular matrix research
Cell Mol Life Sci
BPC stands for Body Protection Compound